Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05647798 · ClinicalTrials.gov registry record · NA
Intrapartum Glycemic Control in GDMA2
A NA study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05647798: Clinical Trial NA study, sponsored by Inova Health Care Services.
NCT05647798 is a NA study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05647798, a NA study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a randomized, parallel, controlled, non-inferiority trial to assess the impact of a tight versus a more liberalized intrapartum glycemic control in gestational diabetic mothers on neonatal glycemia. National guidelines for the management of intrapartum glucose in women with GDM are lacking. This is likely due to the scarcity of high-quality data on the topic.
Primary Outcome
First blood sugar recorded in newborn after delivery
Interventions
- OTHER Blood sugar check every 2 hours
- OTHER Blood sugar check every 4 hours
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-05-22 |
| Est. Completion | 2024-05-15 |
| Phase | NA |
Why NCT05647798 stopped before completion
NCT05647798 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Blood sugar check every 2 hours is the first listed.
NCT05647798 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05647798 about?
NCT05647798 is a clinical study titled "Intrapartum Glycemic Control in GDMA2". This is a randomized, parallel, controlled, non-inferiority trial to assess the impact of a tight versus a more liberalized intrapartum glycemic control in gestational diabetic mothers on neonatal glycemia. National guidelines for the management of intrapartum glucose in women with GDM are lacking. ...
What is the current status of trial NCT05647798?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-05-22. Estimated completion is 2024-05-15.
What interventions are being tested in trial NCT05647798?
The interventions under investigation include: Blood sugar check every 2 hours (OTHER), Blood sugar check every 4 hours (OTHER).
Who is sponsoring clinical trial NCT05647798?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05647798's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI